New study by Professor Yoon-Kyoung Cho validates urine-based biomarkers for early detection of cancer.
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.
In the study, Professor Yoon-Kyoung Cho of Life Science, a group leader at IBS Research Center for Soft and Living Matter (CSLM) presented an integrated centrifugal microfluidic
platform (Exodisc), a device that isolates extracellular vesicles (EVs) from urine.
The results of the study has been published in the February issue of ACS Nano journal. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.
Despite the increasing clinical importance of EVs as potential biomarkers in the diagnosis and prognosis of various diseases, current methods of EV isolation and analysis suffer from complicated procedures with long processing times. For instance, even ultracentrifugation (UC), the most commonly used method for EV isolation, requires time-consuming steps involving centrifugation and acquisition of large sample volumes, and the results suffer from low yield and purity.
To overcome these limitations, Professor Cho presented a new lab-on-a-disc platform for rapid, size-selective, and efficient isolation and analysis of nanoscale EVs from raw biological samples, such as cell-culture supernatant (CCS) or cancer-patient urine.
“The Exodisc is compoased of two independent filteration units (20nm and 600nm in size) within a disk-shaped chip to enable the processing of two different samples simulateously,” says Hyun-Kyung Woo (Combined M.S./Ph.D. student of Natural Science), the first author of the study. “Upon spinning the disc, the urine sample is transferred through two integrated nanofilters, allowing for the enrichment of unirary EVs within the size range of 20 to 600 nm.”
The hole sizes in nanoporous filters mounted on the Exodisc were set arbitrarily to seperate the nanoscale vesicles effectively from germs or unnecessary proteins. The direct detection of urinary EVs from patients with bladder cancer was validated successfully, using on-disc enzyme-linked immunosorbent assay (ELISA).
“Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes,” says Professor Cho. “The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs.”
In the study, the research team examined clinical samples by analyzing urinary EVs from bladder cancer patients, using a tabletop-sized centrifugal microfluidic system. As a result, fully automated enrichment of unirary EVs in the size range of 20?600 nm was achieved within 30 min Quantitative tests.
“On-disc ELISA using urinary EVs isolated from bladder cancer patients showed high levels of CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics,” says Vijaya Sunkara of Life Sciences, the co-first author.
“We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles,” says Professor Cho. “We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings,” says Professor Cho.
Receive an email update when we add a new CANCER DIAGNOSTICS article.
The Latest on: Cancer diagnostics
via Google News
The Latest on: Cancer diagnostics
- Cancer diagnosis linked to high rates of alcohol use, plus more top stories in hematology/oncologyon February 27, 2020 at 9:02 am
A feature on new study data showing over half of patients with a history of cancer diagnosis report high rates of alcohol consumption was the top story in hematology/oncology last week. Another top ...
- 2020 US Cancer Diagnostics Market Segmentation Analysis: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stainson February 27, 2020 at 7:31 am
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget. “22016 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, ...
- Global Molecular Diagnostics Cancer Market 2020 Industry Emerging Trend, Market Players, Revenue Insights to 2026on February 27, 2020 at 5:23 am
A recent report provides crucial insights along with application based and forecast information in the Global Molecular Diagnostics Cancer Market. The report provides a comprehensive analysis of key ...
- 2020 Global Cancer Diagnostics Market Players--Market Shares by Country, Strategic Assessments of Major Suppliers and Emerging Market Entrantson February 27, 2020 at 4:51 am
This new report provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers ...
- VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatmenton February 27, 2020 at 2:26 am
Compared to controls, VEGF-A/VEGF-A165b ratios were decreased in patients before and after chemotherapy. Our data suggests that circulating VEGF-A165b is significantly reduced in women with primary ...
- Tamra Judge Is 'Hugging' Her Kids 'Extra Tight Lately' amid Simon Barney's Cancer Diagnosison February 26, 2020 at 2:50 pm
RELATED: Simon Barney and Tamra Judge Say His Cancer Diagnosis Brought Their Fractured Family Together “I think everything happens for a reason, I think your destiny is pretty much set for you, and ...
- Gretchen Rossi and Slade Smiley Criticize Tamra Judge for 'Media Tour' After Ex Husband's Cancer Diagnosison February 26, 2020 at 10:02 am
In this exclusive clip from Wednesday's launch, the two -- who have long had issues with Tamra dating back to their time on the Bravo series -- called out Judge over the interviews she's done since ...
- East Texan lifts the spirits of patients through music after cancer diagnosison February 26, 2020 at 5:20 am
An East Texas musician is helping to spread joy at the same place where she's getting treatment herself. GMET’s Brennon Gurley introduces us to the woman who's devoted to sharing her talents with ...
- After a rare uterine cancer diagnosis at age 26, she gave birth to a baby boyon February 25, 2020 at 4:07 pm
When the ultrasound revealed a mass on her uterus, Everard was referred to an oncologist who performed a biopsy. The results were shocking: Everard had a rare uterine cancer that impacts 1 in 1 ...
via Bing News